{
    "title": "Alder's shares tumble as migraine drug data disappoints",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4643358/Alders-migraine-drug-data-disappoints-shares-tumble.html",
    "date": "2017-06-27",
    "keywords": [
        "migraine",
        "alder",
        "latestage",
        "treatment",
        "trial",
        "reduction",
        "drug",
        "banerjee",
        "study",
        "percent",
        "year",
        "mg",
        "placebo",
        "iv",
        "analyst",
        "approval",
        "june",
        "investor",
        "clutch",
        "calcitonin",
        "cgrp",
        "protein",
        "amgen",
        "inc",
        "partnership",
        "novartis",
        "ag",
        "application",
        "ltd",
        "dose",
        "eptinezumab",
        "infusion",
        "baseline",
        "therapy",
        "response",
        "context",
        "duncan",
        "market",
        "share",
        "dosing",
        "schedule",
        "administration",
        "question",
        "selfadministration",
        "plan",
        "leerink",
        "paul",
        "matteis",
        "goal",
        "nausea",
        "vomiting",
        "light",
        "lack",
        "sheer",
        "number",
        "enrollment",
        "companys",
        "afternoon",
        "trading",
        "reporting",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}